EGR1 or early growth response 1 is a master regulator of hematopoietic differentiation, and studies demonstrated that the dysregulation of EGR1 is involved in hematologic malignancies such as chronic lymphocytic leukemia and B cell lymphoma [21]. This evidence concerns the gene EGR1 and B-cell chronic lymphocytic leukemia.